A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound

Bibliographic Details
Main Authors: J. Lorenzi, Y. Cohen, L. Burke, M. Caskey, M. Nussenzweig
Format: Article
Language:English
Published: Elsevier 2017-12-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020305562
id doaj-719bcab8a8fb46df814169a90b3c3fc9
record_format Article
spelling doaj-719bcab8a8fb46df814169a90b3c3fc92021-05-05T04:05:54ZengElsevierJournal of Virus Eradication2055-66402017-12-01341A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral reboundJ. Lorenzi0Y. Cohen1L. Burke2M. Caskey3M. Nussenzweig4Rockefeller University, New York, NY, USARockefeller University, New York, NY, USARockefeller University, New York, NY, USARockefeller University, New York, NY, USARockefeller University, New York, NY, USAhttp://www.sciencedirect.com/science/article/pii/S2055664020305562
collection DOAJ
language English
format Article
sources DOAJ
author J. Lorenzi
Y. Cohen
L. Burke
M. Caskey
M. Nussenzweig
spellingShingle J. Lorenzi
Y. Cohen
L. Burke
M. Caskey
M. Nussenzweig
A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound
Journal of Virus Eradication
author_facet J. Lorenzi
Y. Cohen
L. Burke
M. Caskey
M. Nussenzweig
author_sort J. Lorenzi
title A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound
title_short A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound
title_full A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound
title_fullStr A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound
title_full_unstemmed A phase 2 trial to evaluate the effects of 3BNC117 in addition to antiretroviral therapy on the latent reservoir and viral rebound
title_sort phase 2 trial to evaluate the effects of 3bnc117 in addition to antiretroviral therapy on the latent reservoir and viral rebound
publisher Elsevier
series Journal of Virus Eradication
issn 2055-6640
publishDate 2017-12-01
url http://www.sciencedirect.com/science/article/pii/S2055664020305562
work_keys_str_mv AT jlorenzi aphase2trialtoevaluatetheeffectsof3bnc117inadditiontoantiretroviraltherapyonthelatentreservoirandviralrebound
AT ycohen aphase2trialtoevaluatetheeffectsof3bnc117inadditiontoantiretroviraltherapyonthelatentreservoirandviralrebound
AT lburke aphase2trialtoevaluatetheeffectsof3bnc117inadditiontoantiretroviraltherapyonthelatentreservoirandviralrebound
AT mcaskey aphase2trialtoevaluatetheeffectsof3bnc117inadditiontoantiretroviraltherapyonthelatentreservoirandviralrebound
AT mnussenzweig aphase2trialtoevaluatetheeffectsof3bnc117inadditiontoantiretroviraltherapyonthelatentreservoirandviralrebound
AT jlorenzi phase2trialtoevaluatetheeffectsof3bnc117inadditiontoantiretroviraltherapyonthelatentreservoirandviralrebound
AT ycohen phase2trialtoevaluatetheeffectsof3bnc117inadditiontoantiretroviraltherapyonthelatentreservoirandviralrebound
AT lburke phase2trialtoevaluatetheeffectsof3bnc117inadditiontoantiretroviraltherapyonthelatentreservoirandviralrebound
AT mcaskey phase2trialtoevaluatetheeffectsof3bnc117inadditiontoantiretroviraltherapyonthelatentreservoirandviralrebound
AT mnussenzweig phase2trialtoevaluatetheeffectsof3bnc117inadditiontoantiretroviraltherapyonthelatentreservoirandviralrebound
_version_ 1721475712802619392